5-(N-Methyl-2-aminopropyl)-2,3-dihydro-1H-indene (5-MAPDI), also known as indanylmethylaminopropane (IMP), is a putative entactogen and selective serotonin releasing agent (SSRA) of the amphetamine family.[1] 5-MAPDI is not known to have ever been assayed by humans, but based on its close structural similarity to its N-demethylated analogue 5-(2-aminopropyl)-2,3-dihydro-1H-indene (5-APDI), it may have similar effects.[1]

See also